美股A股
StockGist

GE HealthCare Technologies Inc.

GEHCNASDAQ · Healthcare · Medical - Healthcare Information Services
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the di…
$82.96-0.07%
报价 2026-11-16
市值
$37.51B
EV
$45.55B
PE (TTM)
21.8x
预期 PE (FY2026)
16.5x
52 周区间距高点 -5.9%
$59.49$88.16

筛选结果

pipeline · 2026-11-16
Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool

爆发潜力

2026-11-16
未命中✗ 收入线✗ EPS 线
财年收入倍数EPSPE
FY+22027-121.1x4.90 → 5.53(1.1x)15.0
FY+32028-121.1x4.90 → 6.13(1.3x)13.5

毛利率 43% · TTM 收入 $21637M · 基数 EPS 4.90(调整后)

电话会信号

辅助标签
Q3 20262026-10-28
扩产AI 词频高积压订单词频高上调指引供不应求
指引 上调
信心 4
分析师 4

“We feel very good about the $500 million exiting 2028 for Vercado.”

原文引用(3)
  • 扩产:We are investing in strengthening our supply chain and manufacturing capabilities
  • 上调指引:we are raising several of our full year 2026 metrics
  • 供不应求:this market right now today capacity is maxed out

蓝色标签在暴涨研究中略有区分度;悬停查看口径。

研究结论

还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。

去生成基本面报告 →

历史股价

加载中…

事件

0 条 · 随区间与图例筛选

该区间内无事件。

同行对比

FMP 同行列表 · 2026-05-16
公司市值今日预期营收增速毛利率PEEV/EBITDAP/FCF池
GEHCGE HealthCare Technologies Inc.$37.51B-0.1%+6.5%40.3%21.8x14.2x31.5x
CAHCardinal Health, Inc.$65.61B+1.0%+4.1%4.3%31.6x16.9x11.9x
HUMHumana Inc.$55.38B+2.5%+26.1%11.7%43.0x18.3x71.8x
AAgilent Technologies, Inc.$48.76B-0.6%+6.5%26%27.1x23.0x34.0x
ONCBeOne Medicines Ltd.$43.95B-1.3%–86.9%160.5x56.0x–
IQVIQVIA Holdings Inc.$43.63B-0.1%+8.0%32.9%33.1x16.6x16.9x
ALCAlcon Inc.$35.38B-0.6%–54.8%37.0x21.0x–
MTDMettler-Toledo International Inc.$34.36B-0.7%+6.7%57.5%29.1x22.2x39.5x
RMDResMed Inc.$33.5B-0.6%+3.2%61%22.5x15.9x11.8x
同行中位数––+6.6%43.8%32.3x19.6x25.4x

研究全文

L2 基本面 memo

尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。

财务报表

Metric
2026-09-30
Q3 2026
2026-06-30
Q2 2026
2026-03-31
Q1 2026
2025-12-31
Q4 2025
2025-09-30
Q3 2025
2025-06-30
Q2 2025
2025-03-31
Q1 2025
2024-12-31
Q4 2024
Revenue$5.51B$5.3B$5.13B$5.7B$5.14B$5.01B$4.78B$5.32B
Gross Margin40.3%41.2%38.5%39.7%38.7%39.7%42.1%42.8%
Operating Margin14.6%14%10%14.5%12.7%13.1%13.2%15.1%
Net Income$614M$573M$389M$589M$446M$486M$564M$720M
Diluted EPS1.361.240.851.290.981.061.231.57
Operating Cash Flow$907M$-517M$290M$1.05B$593M$94M$250M$913M

研究材料